Wireless Irradiance SEnsors During Neonatal Phototherapy

Launched by MCGILL UNIVERSITY HEALTH CENTRE/RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE · Jun 30, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring a new type of small, wireless device called a bilisensor that can continuously measure the amount of light a newborn baby receives during phototherapy—a common treatment for jaundice, which is a condition where a baby has too much bilirubin in their blood. Right now, doctors usually check the light exposure only once a day using a handheld tool, which might not give a complete picture. This new sensor could help doctors keep a closer eye on the treatment by providing real-time information, making sure each baby gets the right amount of light therapy.

Babies who might take part in this study are those admitted to the Neonatal Intensive Care Unit at Montreal Children’s Hospital, diagnosed with a common type of jaundice called indirect hyperbilirubinemia, weighing more than 1000 grams (about 2.2 pounds), and currently receiving phototherapy. Babies with certain skin problems, a different type of jaundice, or who weigh less than 1000 grams won’t be eligible. If you decide to participate, the sensor would be placed on your baby’s skin during their phototherapy treatment, allowing doctors to monitor light exposure more closely without causing discomfort. Families will be carefully supported throughout to ensure the baby’s safety and well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants must be admitted to the Montreal Children's Hospital (MCH) Neonatal Intensive Care Unit (NICU)
• • Under phototherapy as clinically indicated
• • Diagnosis of indirect hyperbilirubinemia
• • Weight of \>1000g at time of enrollment
• Exclusion Criteria:
• • Any abnormal skin conditions (example: extreme dryness, desquamation, congenital skin disorders, etc.)
• • Diagnosis of direct hyperbilirubinemia
• • Weight of \<1000g at time of enrollment
• • Any baby or family deemed ineligible (ex. too much stress, too unstable) by the clinical care team